MAIA Biotechnology, Inc.
MAIA
$1.59
$0.00530.34%
AMEX
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 16.57% | 36.84% | -23.49% | -35.43% | -14.64% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 35.40% | 37.39% | -21.53% | -15.48% | -18.21% |
| Operating Income | -35.40% | -37.39% | 21.53% | 15.48% | 18.21% |
| Income Before Tax | 39.78% | 44.01% | 42.91% | 43.88% | -96.29% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 39.78% | 44.01% | 42.91% | 43.88% | -96.29% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 39.78% | 44.01% | 42.91% | 43.88% | -96.29% |
| EBIT | -35.40% | -37.39% | 21.53% | 15.48% | 18.21% |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | 55.86% | 64.41% | 64.71% | 67.88% | -13.90% |
| Normalized Basic EPS | 55.86% | 64.43% | 64.69% | 67.86% | -13.90% |
| EPS Diluted | 55.86% | 64.41% | 64.71% | 67.88% | -13.90% |
| Normalized Diluted EPS | 55.86% | 64.43% | 64.69% | 67.86% | -13.90% |
| Average Basic Shares Outstanding | 36.47% | 57.35% | 61.74% | 74.72% | 72.32% |
| Average Diluted Shares Outstanding | 36.47% | 57.35% | 61.74% | 74.72% | 72.32% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |